Sign In
Buy BSEM
$4.14
-0.0290 (-0.696%)
At Close: Jun 03, 2026
BioStem Technologies, Inc. (BSEM) Q1 2025 Earnings Call Transcript
09:54pm, Monday, 12'th May 2025
BioStem Technologies, Inc. (OTCPK:BSEM) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ET Company Participants Adam Holdsworth - Director-Investor Relations Jason Matuszewski - Chief Executive
BioStem Technologies Reports Preliminary First Quarter 2025 Operating and Financial Results
04:00pm, Monday, 12'th May 2025
POMPANO BEACH, FL, May 12, 2025 – PRISM MediaWire – BioStem Technologies, Inc. (OTC: BSEM) (the “Company” or “BioStem”), a leading MedTech company focused on the development, manufacture,
BioStem Technologies Reports Preliminary First Quarter 2025 Operating and Financial Results
04:00pm, Monday, 12'th May 2025
Preliminary net revenue increased 73% to $72.5 million for Q1 2025, compared to $41.9 million in Q1 2024 Achieved preliminary GAAP net income of $4.5 million, or $0.27 per share Reported preliminary Q
BioStem to Showcase its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Spring Meeting
07:01am, Thursday, 01'st May 2025
Company to co-exhibit with strategic partner Venture Medical, LLC, highlighting collaborative innovation in chronic wound care management Three accepted scientific posters will feature BioStem's advan
BioStem to Showcase its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Spring Meeting
07:00am, Thursday, 01'st May 2025
Company to co-exhibit with strategic partner Venture Medical, LLC, highlighting collaborative innovation in chronic wound care management Three accepted scientific posters will feature BioStem's advan
BioStem Technologies to Host First Quarter 2025 Financial Results Conference Call on May 12, 2025
06:58am, Wednesday, 30'th Apr 2025
Conference call and webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., April 30, 2025 – PRISM MediaWire – BioStem Technologies Inc.
BioStem Technologies to Present at the Centri Capital Conference
07:25am, Monday, 21'st Apr 2025
The presentation will be webcast at 10:30 AM ET on April 22, 2025 POMPANO BEACH, Fla., April 21, 2025 – PRISM MediaWire – BioStem Technologies, Inc.
BioStem Technologies to Present at the Centri Capital Conference
07:07am, Monday, 21'st Apr 2025
POMPANO BEACH, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-
BioStem Technologies, Inc. (BSEM) Q4 2024 Earnings Call Transcript
07:03pm, Monday, 14'th Apr 2025
BioStem Technologies, Inc. (OTCPK:BSEM) Q4 2024 Earnings Conference Call April 14, 2025 4:30 PM ET Company Participants Adam Holdsworth - Investor Relations Jason Matuszewski - Chief Executive Officer
POMPANO BEACH, FL, April 14, 2025 – PRISM MediaWire – BioStem Technologies, Inc. (OTC: BSEM) (the “Company” or “BioStem”), a leading MedTech company focused on the development, manufacture
Company reports record preliminary fourth quarter net revenue of $102.9 Million, contributing to a total of $301.8 Million in revenue for 2024 Achieves preliminary GAAP net income of $15.5 million, or
BioStem Technologies to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on April 14, 2025
07:02am, Tuesday, 08'th Apr 2025
Conference Call and Webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., April 08, 2025 – PRISM MediaWire – BioStem Technologies Inc.
BioStem Technologies to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on April 14, 2025
07:00am, Tuesday, 08'th Apr 2025
POMPANO BEACH, Fla., April 08, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-de
BioStem Technologies Announces Extension to File 2024 Annual Report with OTC
04:53pm, Tuesday, 01'st Apr 2025
POMPANO BEACH, Fla., April 1, 2025 – PRISM MediaWire – BioStem Technologies, Inc.
BioStem Technologies Announces Extension to File 2024 Annual Report with OTC
04:49pm, Tuesday, 01'st Apr 2025
POMPANO BEACH, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company specializing in the development, manufacturing, and commercialization of place
